Form D · Pharmaceuticals
Elixir Pharmaceuticals, Inc.
Cambridge, MA · CIK 0001175784
Offering snapshot reported May 28, 2009 · SEC filing
- Reported sold
- $12M Offering amount: $25M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 28, 2009 | Initial | $11,994,995 | No comparison | Not reported | SEC filing |
| Mar 11, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 5, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 3, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-44911
Source: Form D, filed May 28, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vernon Cassin | Director |
| Peter S. Di Stefano | Executive |
| Ansbert Gadicke | Director |
| Kenneth Greenberg | Director |
| Vaughn M. Kailian | Director |
| Robert Kriebel | Executive |
| Dion Madsen | Director |
| Paul M. Martha | Director, Executive |
| Karen Roberts | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12 Emily Street
Cambridge, MA, 02139
Cambridge, MA, 02139